Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Diroximel fumarate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,824Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zydus Gets FDA Nod For Diroximel Fumarate Capsules
    Zydus Gets FDA Nod For Diroximel Fumarate Capsules

    14 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/zydus-receives-fda-final-approval-for-diroximel-fumarate-delayed-release-capsules-231-mg-18228

    INDPHARMAPOST
    14 Nov 2025
    Share Share
    Zydus’s Generics Diroximel Fumarate Receives Approval In US
    Zydus’s Generics Diroximel Fumarate Receives Approval In US

    12 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218596

    FDA
    12 Nov 2025
    Share Share
    GoodRx and Biogen Collaborate to Enhance Enrollment Experience for Providers
    GoodRx and Biogen Collaborate to Enhance Enrollment Experience for Providers

    13 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221013005410/en

    BUSINESSWIRE
    13 Oct 2022
    Share Share
    SMC approves diroximel fumarate as multiple sclerosis treatment
    SMC approves diroximel fumarate as multiple sclerosis treatment

    08 Feb 2022

    // PHARMAFILE

    http://www.pharmafile.com/news/606044/smc-approves-diroximel-fumarate-multiple-sclerosis-treatment

    PHARMAFILE
    08 Feb 2022
    Share Share
    MHRA authorises Vumerity for multiple sclerosis patients
    MHRA authorises Vumerity for multiple sclerosis patients

    19 Nov 2021

    // Lucy Parsons PHARMATIMES

    https://www.pharmatimes.com/news/mhra_authorises_vumerity_for_multiple_sclerosis_patients_1383757

    Lucy Parsons PHARMATIMES
    19 Nov 2021
    Share Share
    European Commission grants marketing authorisation for Vumerity
    European Commission grants marketing authorisation for Vumerity

    17 Nov 2021

    // Anna Begley EUROPEANPHARMACEUTICALREVIEW

    https://www.europeanpharmaceuticalreview.com/news/165570/european-commission-grants-marketing-authorisation-for-vumerity/

    Anna Begley EUROPEANPHARMACEUTICALREVIEW
    17 Nov 2021
    Share Share